Skip to content
SearchProgress
Display

Display

Theme
Density
Text size

Sign in

Add your earlier progress to your account?

Study progress is waiting to be saved

The antibody screen

14 min

  • Explain why group O reagent cells are used for unexpected-antibody screening
  • Name the antibodies a negative screen can miss and the checks that still apply
  • Accept or reject a crossmatch sample by its age and the transfusion and pregnancy history

Read the full reference

Try first

Try first

A two-cell antibody screen is nonreactive. Cell 1 is Jk(a+b+) and cell 2 is Jk(a−b+). Could a weak anti-Jka still be present?

The next section explains it.

The next section explains it.

Right. The next section explains why.

The next section explains it.

The next section explains it.

Get the idea

Group O screening cells

The antibody screen tests the patient's plasma against two or three group O reagent red cells with known antigen profiles. Group O cells lack A and B, so the patient's expected anti-A and anti-B have nothing to react with. A reaction points to an unexpected antibody.1,2

Across the lot, the cells carry D, C, E, c, e, K, k, Fya, Fyb, Jka, Jkb, Lea, Leb, P1, M, N, S and s. Each cell is tested on its own, and the lot's antigen profile lists what each cell carries.3

What a negative screen means

A nonreactive screen shows no antibody detectable against the antigens on those cells, under those test conditions.1,4 It can miss:

  • a weak antibody, or one that has fallen below detection since it formed
  • an antibody that shows dosage, when the cells carry only a single dose of its antigen
  • an antibody to a low-prevalence antigen that the cells lack and a donor unit carries

The patient's antibody history still decides unit selection when today's screen is nonreactive. A recorded clinically significant antibody calls for antigen-negative red cells and an antiglobulin crossmatch.1,2

How old a specimen can be

Transfusion and pregnancy can start a new antibody within days. Federal rules require a specimen less than 3 days old when the patient was transfused or pregnant in the preceding 3 months.5 The collection date is day 0, and the specimen expires at midnight on day 3. AABB standards apply the same limit when the history is unknown or uncertain.1,2 A longer interval needs a reliable negative history and a defined facility policy.2,6

References
  1. Bloch EM, Campbell-Lee S, McKenna DH Jr, Montemayor-Garcia C, Schwartz J, Shaz B, Storry J, eds. Technical Manual. 22nd ed. AABB; 2026.
  2. Association for the Advancement of Blood & Biotherapies. Fundamental Standards for Blood Collection and Transfusion. 2nd ed. AABB; 2025. Accessed September 27, 2026.
  3. Testing of source material, 21 CFR §660.33 (2026). Accessed September 27, 2026. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-F/part-660/subpart-D/section-660.33
  4. Immucor, Inc. Panoscreen Reagent Red Blood Cells Package Insert. US Food and Drug Administration. Accessed September 27, 2026.
  5. Compatibility testing, 21 CFR §606.151 (2026). Accessed September 27, 2026. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-F/part-606/subpart-C/section-606.151
  6. Association for the Advancement of Blood & Biotherapies. Standards for Blood Banks and Transfusion Services. 35th ed. AABB; 2026. Accessed September 27, 2026.

Watch one

Tobias Lindqvist, 66, is typed and screened before hip surgery. His record shows anti-Jka identified 2 years ago. Today's three-cell screen reads:

The check cells agglutinated in every tube. What does the screen show, and which red cells does he receive?

Antibody panel: + the cell carries the antigen, 0 it lacks it
CellDCEceKkFyaFybJkaJkbMNSsP1LeaLeb37AHG
1++00++++0+++0+++0+00
2+0++00+0+0+0+0+0+000
3000++0++++0++0++0+00
  1. Check validity first. Every cell is 0 at 37 °C and the antiglobulin phase, and the check cells agglutinated.

    A negative tube reading counts only when the check cells show the antihuman globulin was active.

  2. Read the Kidd antigens. Cell 3 is Jk(a+b−), a double dose of Jka, and it is nonreactive.

    A double-dose cell gives a weak Kidd antibody its best chance to react.

  3. State what the screen supports. No anti-Jka is detectable today.

    Kidd antibodies can fall below detection and return within days of re-exposure.

  4. Pull up the record. The anti-Jka identified 2 years ago stays on it.

    A recorded clinically significant antibody decides unit selection whatever today's screen shows.

  5. Select Jk(a−) red cells and crossmatch them through the antiglobulin phase.

    A history of a clinically significant antibody removes the ABO-only crossmatch pathway.

The screen is reported as nonreactive. He receives Jk(a−) red cells with an antiglobulin crossmatch, because his anti-Jka history stands.

Your turn

Problem 1 of 3

A valid antibody screen is nonreactive. Which interpretation is supported?

Incorrect. Historical records remain necessary because past antibodies can become undetectable.

Incorrect. A donor may carry an antigen absent from the screening cells, and other incompatibility causes remain possible.

Correct. The conclusion is bounded by reagent antigen expression, antibody concentration, and method sensitivity.

Hint
  1. A screen tests one set of reagent cells under one set of conditions.
  2. Ask which options claim something about cells or times the screen never tested.

Review Unexpected-antibody detection

Problem 2 of 3

Why are the reagent red cells in an antibody screen group O?

ABO group does not set Rh antigen density. Each cell's Rh antigens are listed on the lot profile.

Any reaction with group O cells then points to an unexpected antibody, whatever the patient's ABO group.

Donors of any group can carry these antigens. The group matters because of the patient's expected ABO antibodies.

The screen looks for antibodies in the patient's plasma. It makes no prediction about any donor unit.

Hint
  1. Ask what every patient's plasma may hold apart from unexpected antibodies.
  2. Recall the expected antibodies of a group A patient and of a group B patient.

Review Unexpected-antibody detection

Problem 3 of 3

A patient was transfused 5 weeks ago. Her specimen was collected on Monday at 06:00. On Thursday at 10:00 a crossmatch is requested on that specimen. Can it be used?

Monday is day 0, and Thursday is day 3. The specimen expires at midnight on day 3.

The limit counts dates. Monday is day 0, and the specimen lasts until midnight on day 3.

The rule allows a specimen less than 3 days old. A same-day specimen is not required.

Her transfusion 5 weeks ago sets the 3-day limit. A nonreactive screen shows only the antibodies present when the specimen was drawn.

Review Identity, specimen, and history

Use it

  • Hollis Varga, 58, a long-haul trucker, MRN 7730418, arrives unresponsive after a highway crash. No transfusion history can be found.
  • A type and screen was collected on Sunday at 14:00.
  • On Friday, surgery asks for 2 red cell units on that specimen.
  • The facility's policy allows a specimen up to 14 days old for a patient with a reliable negative history.
Decision 1 of 3

Can the Sunday specimen be used?

The longer interval needs a reliable negative history. His history is unknown, so the 3-day limit applies.

Applied a longer sample interval when history was unknown

A patient transfused or pregnant in the past 3 months can form a new red-cell antibody within days, and an older sample would miss it. Federal rules require a sample less than 3 days old for these patients, and AABB standards apply the same limit when the history is unknown or uncertain. A longer interval needs a reliable negative history and a defined facility policy.

A reliable negative history comes from records or a reliable account. He has neither, so his history is unknown.

With an unknown history the 3-day limit applies. Sunday is day 0, and the specimen expired at midnight on Wednesday, day 3.

Review Identity, specimen, and history

Antibody panel: + the cell carries the antigen, 0 it lacks it
CellDCEceKkFyaFybJkaJkbMNSsP1LeaLeb37AHG
1++00++++++++++0+0+00
2+0++00++00+0+0+++000
Decision 2 of 3

The new specimen's two-cell screen reads as shown. Which antibody could it most easily miss?

Cell 2 is E+e−, a double dose of E, and it is nonreactive. A weak anti-E would most likely react with it.

Both cells carry D and both are nonreactive. Anti-D would react with either.

Cell 1 carries K and is nonreactive. Kell antibodies do not depend on a double dose to react.

Only cell 1 carries Jka, and it is Jk(a+b+), a single dose. A weak Kidd antibody can miss a single dose.

Review Unexpected-antibody detection

Decision 3 of 3

The new specimen was collected on Friday at 09:00. Until when can it be used for crossmatching?

The limit counts dates. Friday is day 0, and the specimen lasts until midnight on day 3.

Friday is day 0, Saturday day 1, Sunday day 2 and Monday day 3. It expires at midnight on Monday.

That counts Friday as day 1. The collection date is day 0.

Review Identity, specimen, and history

The clue that settled this case is his unknown history. It set the 3-day limit on both specimens. It also means the nonreactive screen, with only a single dose of Jka on its cells, is the whole of what is known about his antibodies.

Keep

Sources checked